Covered recipient · General Payments record
ANDREEA C VASCAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$347.39
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $206.11 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $84.26 | 4 |
| Abbott Laboratories | $27.64 | 1 |
| GlaxoSmithKline, LLC. | $22.51 | 1 |
| DEXCOM, INC. | $21.29 | 1 |
| PFIZER INC. | $20.17 | 1 |
| Acerta Pharma LLC | $15.32 | 1 |
| Esperion Therapeutics, Inc. | $14.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $27.64 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125360561 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.32 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104650073 | CMS |
| Dexcom, Inc. | $21.29 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153279307 | CMS |
| Esperion Therapeutics, Inc. | $14.92 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129458802 | CMS |
| GlaxoSmithKline, LLC. | $22.51 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116446266 | CMS |
| Novo Nordisk Inc | $19.39 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097705738 | CMS |
| Novo Nordisk Inc | $24.90 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097599137 | CMS |
| Novo Nordisk Inc | $20.70 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097545217 | CMS |
| Novo Nordisk Inc | $19.27 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097768690 | CMS |
| PFIZER INC. | $20.17 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131994425 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.